entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 03:39:57 - browse：63

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Class action alleges UnitedHealth concealed DOJ probe

WSS

Warren pushes Witty on UnitedHealth's control over physicians

AltruBio raises $225 million to develop ulcerative colitis drug

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare has a new plan to address drug shortages

Lawmakers grill UnitedHealth CEO on Change cyberattack

How Medicaid coverage policies for immigrants impact new moms

explore

entertainment

Wikipedia

Virginia high school admissions case could be legal follow

Can gargling with Listerine treat gonorrhea of the mouth?

As demand for Covid shots wanes, Moderna seeks its next success

Crowdfunding for medical bills sidesteps core problem, author says

How to save PrEP access — and even expand it

Primary care doctor shortage won't be solved by free med school tuition

Alkermes shareholders re

Why hospitals are withdrawing from US News rankings

Jerome Adams on the need for new antivirals for Covid

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Wikipedia

Cosmetics set for new safety regulation. Why the industry is on board

Custom gene therapy hints at new path for rare disease treatments

How dance can help nurses traumatized by Covid

Is it ever OK for doctors to lie to their patients?

Class action alleges UnitedHealth concealed DOJ probe

AI can’t replace a physician’s gut feeling

knowledge

hotspot

focus

hotspot